The FASEB Journal, Vol 4, 3234-3238, Copyright © 1990 by The Federation of American Societies for Experimental Biology

RESEARCH COMMUNICATIONS

Apparent mineralocorticoid excess, pseudohypoaldosteronism, and urinary electrolyte excretion: toward a redefinition of mineralocorticoid action

JW Funder, PT Pearce, K Myles and LP Roy
Medical Research Centre, Prince Henry's Hospital, Melbourne, Victoria, Australia.

Patients with apparent mineralocorticoid excess (AME) have low or absent activity of the enzyme 11 beta OH steroid dehydrogenase (11SD), and inappropriately high intrarenal levels of cortisol resulting in Na+ retention and hypertension. Pseudohypoaldosteronism (PHA), in contrast, is characterized by salt wasting despite hyperaldosteronemia, reflecting low or absent mineralocorticoid receptors (MR). Although AME is presumed to reflect inappropriate cortisol occupancy of MR, several features also suggest inappropriate occupancy of glucocorticoid receptors (GR). To test this possibility, we administered carbenoxolone, which is known to block 11SD, to four patients with PHA, and observed marked mineralocorticoid effects, e.g., antinatriuresis and elevated plasma bicarbonate. To further test the possibility that occupancy of renal GR may induce a classical mineralocorticoid response, we administered the highly specific glucocorticoid RU 28362 to adrenalectomized rats and showed that it has profound antinatriuretic effects. Finally, by selectively blocking MR with RU 28318 or GR with RU 38486, we have shown that corticosterone, the physiologic glucocorticoid in rats, has an antinatriuretic effect in adrenalectomized rats via either MR or GR occupancy. Previous studies have clearly shown that MR are inherently nonselective and have equivalent intrinsic affinity for aldosterone, corticosterone, and cortisol. The present studies suggest that this nonselectivity includes the nuclear response element to which either MR or GR may bind to elicit a mineralocorticoid effect, and further underscore the importance of the enzyme 11SD in the specific mineralocorticoid action of aldosterone.

This article has been cited by other articles:

				A. Turchin, C. Z. Guo, G. K. Adler, V. Ricchiuti, I. S. Kohane, and G. H. Williams Effect of Acute Aldosterone Administration on Gene Expression Profile in the Heart Endocrinology, July 1, 2006; 147(7): 3183 - 3189. [Abstract] [Full Text] [PDF]

				N. Marissal-Arvy and P. Mormede Excretion of electrolytes in Brown Norway and Fischer 344 rats: effects of adrenalectomy and of mineralocorticoid and glucocorticoid receptor ligands Exp Physiol, November 1, 2004; 89(6): 753 - 765. [Abstract] [Full Text] [PDF]

				W. Qin, A. E. Rudolph, B. R. Bond, R. Rocha, E. A.G. Blomme, J. J. Goellner, J. W. Funder, and E. G. McMahon Transgenic Model of Aldosterone-Driven Cardiac Hypertrophy and Heart Failure Circ. Res., July 11, 2003; 93(1): 69 - 76. [Abstract] [Full Text] [PDF]

				M. J. Young, L. Moussa, R. Dilley, and J. W. Funder Early Inflammatory Responses in Experimental Cardiac Hypertrophy and Fibrosis: Effects of 11{beta}-Hydroxysteroid Dehydrogenase Inactivation Endocrinology, March 1, 2003; 144(3): 1121 - 1125. [Abstract] [Full Text] [PDF]

				A. Bhargava, M. J. Fullerton, K. Myles, T. M. Purdy, J. W. Funder, D. Pearce, and T. J. Cole The Serum- and Glucocorticoid-Induced Kinase Is a Physiological Mediator of Aldosterone Action Endocrinology, April 1, 2001; 142(4): 1587 - 1594. [Abstract] [Full Text]

				K. Arai, K. Zachman, T. Shibasaki, and G. P. Chrousos Polymorphisms of Amiloride-Sensitive Sodium Channel Subunits in Five Sporadic Cases of Pseudohypoaldosteronism: Do They Have Pathologic Potential? J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2434 - 2437. [Abstract] [Full Text]

				J. W. Funder Editorial: 15-Hydroxyprostaglandin Dehydrogenase: Cinderella Meets Prince Serendip J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 393 - 394. [Full Text]

				S.-Y. Chen, J. Wang, W. Liu, and D. Pearce Aldosterone responsiveness of A6 cells is restored by cloned rat mineralocorticoid receptor Am J Physiol Cell Physiol, January 1, 1998; 274(1): C39 - C46. [Abstract] [Full Text] [PDF]

				K. X. Z. Li, V. R. Obeyesekere, Z. S. Krozowski, and P. Ferrari Oxoreductase and Dehydrogenase Activities of the Human and Rat 11{beta}-Hydroxysteroid Dehydrogenase Type 2 Enzyme Endocrinology, July 1, 1997; 138(7): 2948 - 2952. [Abstract] [Full Text] [PDF]

				G. W. Souness and D. J. Morris 11{alpha}- and 11ß-Hydroxyprogesterone, Potent Inhibitors of 11ß-Hydroxysteroid Dehydrogenase, Possess Hypertensinogenic Activity in the Rat Hypertension, March 1, 1996; 27(3): 421 - 425. [Abstract] [Full Text]

				J. Funder Mineralocorticoids, glucocorticoids, receptors and response elements Science, February 19, 1993; 259(5098): 1132 - 1133. [PDF]

				A. Odermatt, P. Arnold, and F. J. Frey The Intracellular Localization of the Mineralocorticoid Receptor Is Regulated by 11beta -Hydroxysteroid Dehydrogenase Type 2 J. Biol. Chem., July 20, 2001; 276(30): 28484 - 28492. [Abstract] [Full Text] [PDF]